Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Neuropathy: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neuropathy is a disease characterized by neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 350 entities in the SciDEX knowledge graph.
| Morphology | immature neuron (source: Cell Ontology) |
| Associated Genes | PMP22, OVERVIEW, TNF, VEGF, BECN1, ERBB2, ERBB3, AMPK |
| KG Connections | 603 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Neuropathy["Neuropathy"] -.->|"inhibits"| Lysosomal_Degradation["Lysosomal Degradation"]
Neuropathy["Neuropathy"] -.->|"inhibits"| Blood_Brain_Barrier["Blood-Brain Barrier"]
Neuropathy["Neuropathy"] -->|"activates"| Inflammasome["Inflammasome"]
Neuropathy["Neuropathy"] -->|"activates"| Complement["Complement"]
Neuropathy["Neuropathy"] -->|"regulates"| Cholesterol["Cholesterol"]
Neuropathy["Neuropathy"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
FCGRT["FCGRT"] -->|"regulates"| Neuropathy["Neuropathy"]
NLRP3["NLRP3"] -->|"activates"| Neuropathy["Neuropathy"]
C1Q["C1Q"] -->|"activates"| Neuropathy["Neuropathy"]
PMP22["PMP22"] -->|"associated"| Neuropathy["Neuropathy"]
style Neuropathy fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 0.95 |
| Diabetes | associated_with | disease | 0.85 |
| Inflammasome | activates | pathway | 0.80 |
| Oxidative Stress | therapeutic_target | pathway | 0.80 |
| Oxidative Stress | activates | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Autophagy | activates | pathway | 0.70 |
| Mitophagy | activates | pathway | 0.70 |
| Inflammation | associated_with | disease | 0.65 |
| Type 2 Diabetes | associated_with | disease | 0.65 |
| Type 2 Diabetes | activates | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Insulin Resistance | activates | disease | 0.65 |
| Diabetes | implicated_in | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Lysosomal Degradation | inhibits | pathway | 0.60 |
| Blood-Brain Barrier | inhibits | pathway | 0.60 |
| Complement | activates | pathway | 0.60 |
| Cholesterol | regulates | pathway | 0.60 |
| Apoptosis | therapeutic_target | pathway | 0.60 |
| Lipid Metabolism | associated_with | pathway | 0.60 |
| Insulin Signaling | associated_with | pathway | 0.60 |
| Exocytosis | associated_with | pathway | 0.60 |
| Mitochondrial Function | therapeutic_target | pathway | 0.60 |
| Oxidative Phosphorylation | therapeutic_target | pathway | 0.60 |
| Autophagy | associated_with | pathway | 0.60 |
| Mitophagy | implicated_in | pathway | 0.60 |
| Differentiation | implicated_in | pathway | 0.60 |
| Unfolded Protein Response | implicated_in | pathway | 0.60 |
| Neurogenesis | therapeutic_target | pathway | 0.60 |
| Mapk | therapeutic_target | pathway | 0.60 |
| Nf-Κb | therapeutic_target | pathway | 0.60 |
| Tnf Signaling | inhibits | pathway | 0.60 |
| Sphingolipid | associated_with | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Epigenetic | activates | pathway | 0.60 |
| Differentiation | activates | pathway | 0.60 |
| Cell Division | activates | pathway | 0.60 |
| Cell Cycle | activates | pathway | 0.60 |
| Mitochondrial Function | activates | pathway | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| Dna Methylation | protects_against | pathway | 0.60 |
| Apoptosis | protects_against | pathway | 0.60 |
| Differentiation | protects_against | pathway | 0.60 |
| Epigenetic | protects_against | pathway | 0.60 |
| Invasion | associated_with | pathway | 0.60 |
| Angiogenesis | associated_with | pathway | 0.60 |
| Tumor Microenvironment | associated_with | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | activates | gene | 0.95 |
| PARKIN | activates | gene | 0.85 |
| PINK1 | activates | gene | 0.85 |
| DIABETES MELLITUS | activates | gene | 0.85 |
| INSULIN RESISTANCE | activates | gene | 0.85 |
| AUTOPHAGY | activates | gene | 0.85 |
| INFLAMMATION | therapeutic_target | gene | 0.85 |
| ATP | activates | gene | 0.85 |
| NLRP3 | activates | gene | 0.75 |
| GENES | activates | gene | 0.75 |
| CANCER | therapeutic_target | gene | 0.75 |
| MICROGLIA | activates | gene | 0.75 |
| MITOPHAGY | activates | gene | 0.75 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.75 |
| APOPTOSIS | activates | gene | 0.75 |
| OXIDATIVE STRESS | activates | gene | 0.75 |
| SIRT1 | activates | gene | 0.75 |
| NEURODEGENERATION | associated_with | gene | 0.75 |
| INFLAMMATION | associated_with | gene | 0.75 |
| AUTOPHAGY | associated_with | gene | 0.75 |
| NEURODEGENERATION | activates | gene | 0.75 |
| PMP22 | causes | gene | 0.75 |
| MYELIN | causes | gene | 0.75 |
| NEURODEGENERATION | protects_against | gene | 0.75 |
| ASTROCYTE | activates | gene | 0.75 |
| INFLAMMATION | activates | gene | 0.75 |
| MITOCHONDRIA | activates | gene | 0.75 |
| ROS | activates | gene | 0.75 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.75 |
| NFL | associated_with | gene | 0.75 |
| FCGRT | regulates | gene | 0.65 |
| C1Q | activates | gene | 0.65 |
| PMP22 | associated_with | gene | 0.65 |
| P75NTR | interacts_with | gene | 0.65 |
| VEGF | expressed_in | gene | 0.65 |
| TNF | expressed_in | gene | 0.65 |
| MMP9 | therapeutic_target | gene | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| OVERVIEW | associated_with | gene | 0.65 |
| C1Q | therapeutic_target | gene | 0.65 |
| NLRP3 | therapeutic_target | gene | 0.65 |
| P75NTR | inhibits | gene | 0.65 |
| TNF | associated_with | gene | 0.65 |
| VEGF | associated_with | gene | 0.65 |
| BECN1 | associated_with | gene | 0.65 |
| CTS | expressed_in | gene | 0.65 |
| OVERVIEW | expressed_in | gene | 0.65 |
| RET | inhibits | gene | 0.65 |
| ERBB2 | associated_with | gene | 0.65 |
| GENES | inhibits | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||